Cyte initiates patient dosing in a new trial for famzeretcel, aiming to transform treatment options for retinitis pigmentosa.

The two aim to develop a potential first-in-class melanocortin receptor-targeted treatment for patients with retinal diseases ...

RAMQ is a public organization introduced in 1970, following the adoption of the universal health care system in Canada.

“Larvae without vestibular sensory experience, but whose neuromuscular junction was mature, had a strong vestibulo-ocular reflex. Development of the neuromuscular junction, and not sensory experience, ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

Eyestem Research secures $10 million funding to advance innovative retinal therapies, aiming for global expansion and ...

D Molecular Therapeutics advances 4D-150 for wet AMD and DME, revealing promising trial results and regulatory progress for ...

A complex case of uveitis linked to syphilis highlights the need for thorough history-taking and multidisciplinary management ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

As Ophthalmology Times celebrates its 50th anniversary, the moment serves as an opportunity to reflect on the innovations ...